单基因疾病治疗性基因编辑的当前进展
Current Progress in Therapeutic Gene Editing for Monogenic Diseases.
作者信息
Prakash Versha, Moore Marc, Yáñez-Muñoz Rafael J
机构信息
School of Biological Sciences, Royal Holloway, University of London, Egham, Surrey, UK.
出版信息
Mol Ther. 2016 Mar;24(3):465-74. doi: 10.1038/mt.2016.5. Epub 2016 Jan 14.
Abstract
Programmable nucleases allow defined alterations in the genome with ease-of-use, efficiency, and specificity. Their availability has led to accurate and widespread genome engineering, with multiple applications in basic research, biotechnology, and therapy. With regard to human gene therapy, nuclease-based gene editing has facilitated development of a broad range of therapeutic strategies based on both nonhomologous end joining and homology-dependent repair. This review discusses current progress in nuclease-based therapeutic applications for a subset of inherited monogenic diseases including cystic fibrosis, Duchenne muscular dystrophy, diseases of the bone marrow, and hemophilia and highlights associated challenges and future prospects.
摘要
可编程核酸酶能够轻松、高效且特异地对基因组进行特定改变。它们的出现使得准确且广泛的基因组工程成为可能，在基础研究、生物技术和治疗等多个领域都有应用。在人类基因治疗方面，基于核酸酶的基因编辑推动了基于非同源末端连接和同源依赖性修复的多种治疗策略的发展。本文综述了基于核酸酶的治疗应用在包括囊性纤维化、杜氏肌营养不良、骨髓疾病和血友病在内的一部分遗传性单基因疾病方面的当前进展，并强调了相关挑战和未来前景。
相似文献
1
Current Progress in Therapeutic Gene Editing for Monogenic Diseases.单基因疾病治疗性基因编辑的当前进展
Mol Ther. 2016 Mar;24(3):465-74. doi: 10.1038/mt.2016.5. Epub 2016 Jan 14.
2
Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases.近年来遗传性心血管疾病的基因组编辑方法研究进展
Curr Cardiol Rep. 2018 Jun 2;20(7):58. doi: 10.1007/s11886-018-0998-3.
3
Genome editing in large animal models.大型动物模型中的基因组编辑。
Mol Ther. 2021 Nov 3;29(11):3140-3152. doi: 10.1016/j.ymthe.2021.09.026. Epub 2021 Oct 1.
4
Genome-editing Technologies for Gene and Cell Therapy.用于基因和细胞治疗的基因组编辑技术
Mol Ther. 2016 Mar;24(3):430-46. doi: 10.1038/mt.2016.10. Epub 2016 Jan 12.
5
Therapeutic genome editing with engineered nucleases.使用工程核酸酶进行治疗性基因组编辑。
Hamostaseologie. 2017 Jan 31;37(1):45-52. doi: 10.5482/HAMO-16-09-0035. Epub 2017 Jan 10.
6
Gene therapy comes of age.基因治疗走向成熟。
Science. 2018 Jan 12;359(6372). doi: 10.1126/science.aan4672.
7
The delivery challenge: fulfilling the promise of therapeutic genome editing.递送挑战：实现治疗性基因组编辑的承诺。
Nat Biotechnol. 2020 Jul;38(7):845-855. doi: 10.1038/s41587-020-0565-5. Epub 2020 Jun 29.
8
Genome Editing Techniques and Their Therapeutic Applications.基因组编辑技术及其治疗应用。
Clin Pharmacol Ther. 2017 Jan;101(1):42-51. doi: 10.1002/cpt.542. Epub 2016 Nov 18.
9
Point: Treating Human Genetic Disease One Base Pair at a Time: The Benefits of Gene Editing.观点：一次处理一个碱基对治疗人类遗传疾病：基因编辑的益处。
Clin Chem. 2018 Mar;64(3):486-488. doi: 10.1373/clinchem.2017.278309.
10
Acceptance and Access to Gene Editing: Science and Our Obligations to Mankind.基因编辑的接受与应用：科学及我们对人类的责任
Mol Ther. 2017 Jan 4;25(1):1-2. doi: 10.1016/j.ymthe.2016.12.012. Epub 2016 Dec 28.
引用本文的文献
1
The Interface of Gene Editing with Regenerative Medicine.基因编辑与再生医学的界面
Engineering (Beijing). 2025 Mar;46:73-100. doi: 10.1016/j.eng.2024.10.019. Epub 2024 Nov 30.
2
Regional patterns of genetic variants in expanded carrier screening: a next-generation sequencing pilot study in Fujian Province, China.扩展携带者筛查中基因变异的区域模式：中国福建省的一项二代测序试点研究
Front Genet. 2025 May 12;16:1527228. doi: 10.3389/fgene.2025.1527228. eCollection 2025.
3
Male gamete copies to characterize genome inheritance and generate progenies.雄性配子拷贝用于表征基因组遗传并产生后代。
Sci Rep. 2025 May 4;15(1):15600. doi: 10.1038/s41598-025-99188-1.
4
Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives.单基因疾病的质粒基因治疗：挑战与展望
Pharmaceutics. 2025 Jan 14;17(1):104. doi: 10.3390/pharmaceutics17010104.
5
Axonal Regeneration after Spinal Cord Injury: Molecular Mechanisms, Regulatory Pathways, and Novel Strategies.脊髓损伤后的轴突再生：分子机制、调控途径及新策略
Biology (Basel). 2024 Sep 7;13(9):703. doi: 10.3390/biology13090703.
6
In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells.经子宫内递送达靶可离子化脂质纳米颗粒促进了造血干细胞的体内基因编辑。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2400783121. doi: 10.1073/pnas.2400783121. Epub 2024 Jul 30.
7
Rapid Whole-Genome Sequencing and Clinical Management in the PICU: A Multicenter Cohort, 2016-2023.快速全基因组测序与 PICU 的临床管理：一项多中心队列研究，2016-2023 年。
Pediatr Crit Care Med. 2024 Aug 1;25(8):699-709. doi: 10.1097/PCC.0000000000003522. Epub 2024 Apr 26.
8
Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients.为评估肾移植受者的并发症开发基因检测面板。
Kidney Int. 2024 Jul;106(1):115-125. doi: 10.1016/j.kint.2024.02.021. Epub 2024 Mar 21.
9
Engineered mischarged transfer RNAs for correcting pathogenic missense mutations.用于校正致病性错义突变的工程化错配转运RNA
Mol Ther. 2024 Feb 7;32(2):352-371. doi: 10.1016/j.ymthe.2023.12.014. Epub 2023 Dec 16.
10
Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec.为未来基因疗法铺平道路：以德蓝地昔洛韦（delandistrogene moxeparvovec）的科学溢出效应为例
Mol Ther Methods Clin Dev. 2023 Aug 9;30:474-483. doi: 10.1016/j.omtm.2023.08.002. eCollection 2023 Sep 14.
本文引用的文献
1
A mechanism for the suppression of homologous recombination in G1 cells.G1期细胞中同源重组抑制的一种机制。
Nature. 2015 Dec 17;528(7582):422-6. doi: 10.1038/nature16142. Epub 2015 Dec 9.
2
Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.Cpf1是2类CRISPR-Cas系统中的一种单RNA引导的内切核酸酶。
Cell. 2015 Oct 22;163(3):759-71. doi: 10.1016/j.cell.2015.09.038. Epub 2015 Sep 25.
3
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.通过Cas9介导的原位饱和诱变对BCL11A增强子进行剖析
Nature. 2015 Nov 12;527(7577):192-7. doi: 10.1038/nature15521. Epub 2015 Sep 16.
4
Functional footprinting of regulatory DNA.调控DNA的功能足迹分析
Nat Methods. 2015 Oct;12(10):927-30. doi: 10.1038/nmeth.3554. Epub 2015 Aug 31.
5
Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs.对患者诱导多能干细胞来源的肺上皮细胞进行囊性纤维化的功能性基因校正。
Cell Rep. 2015 Sep 1;12(9):1385-90. doi: 10.1016/j.celrep.2015.07.062. Epub 2015 Aug 20.
6
In vivo genome editing of the albumin locus as a platform for protein replacement therapy.作为蛋白质替代疗法平台的白蛋白基因座体内基因组编辑。
Blood. 2015 Oct 8;126(15):1777-84. doi: 10.1182/blood-2014-12-615492. Epub 2015 Aug 21.
7
Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9.利用 CRISPR-Cas9 技术对血友病 A 患者诱导多能干细胞中大型凝血因子 VIII 基因染色体倒位进行功能矫正。
Cell Stem Cell. 2015 Aug 6;17(2):213-20. doi: 10.1016/j.stem.2015.07.001. Epub 2015 Jul 23.
8
9
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.反复雾化非病毒 CFTR 基因治疗囊性纤维化患者：一项随机、双盲、安慰剂对照、2b 期试验。
Lancet Respir Med. 2015 Sep;3(9):684-691. doi: 10.1016/S2213-2600(15)00245-3. Epub 2015 Jul 3.
10
Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model.在prkdc缺陷的诱导多能干细胞疾病模型中通过靶向基因组编辑挽救DNA-PK信号传导和T细胞分化
PLoS Genet. 2015 May 22;11(5):e1005239. doi: 10.1371/journal.pgen.1005239. eCollection 2015 May.
Zotero 插件